Target intelligence / Profile preview

Ribosomal protein L37 pseudogene 23 (RPL37P23)

Target: RPL37P23
Molecular classification: Other

Overview

Ribosomal protein L37 pseudogene 23 (RPL37P23) is a gene sequence in the human genome homologous to the protein-coding ribosomal protein L37 gene. As a pseudogene, RPL37P23 does not encode a functional protein or participate in ribosomal assembly or protein synthesis. Pseudogenes like RPL37P23 are typically non-functional remnants of genes that may occasionally play regulatory roles, such as influencing gene expression as noncoding RNAs or having evolutionary significance, but there is no evidence that RPL37P23 has any therapeutic, biomarker, or disease roles. Its parent gene, RPL37, encodes a component of the large 60S ribosomal subunit involved in protein synthesis[1][6].

Other names: ribosomal protein L37 pseudogene 23RPL37P23

Beyond the preview

Go deeper on Ribosomal protein L37 pseudogene 23 (RPL37P23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L37 pseudogene 23 (RPL37P23).

Explore the full profile